Virginia Contract Research Organization Co., Ltd.

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Not yet recruiting	Phase 2	2026-09-29	NCT07386002
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2026-09-01	NCT05304481
A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients With Psoriasis	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Not yet recruiting	Phase 2	2026-08-07	NCT06620692
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee	arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, rheumatic disorder	Active, not recruiting	Phase 3	2026-07-27	NCT05318521
A Study of GM-XANTHO in Pressure Ulcer Patients	Nutritional and Metabolic Diseases, Skin Ulcer, Skin and Connective Tissue Diseases, decubitus ulcer, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, skin disorder	Not yet recruiting	Phase 2	2025-09-03	NCT05199077

Clinical trials